|
⚲
|
| Keyboard |
| Meek David D
✚
|
|
|---|---|
| CIK # | 0001555337 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001555337] | |
| 4 | [0001555337] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cullinan Therapeutics Inc | |
| Meek David D | |
| uniQure NV | |
| Fusion Pharmaceuticals Inc | |
| Mirati Therapeutics Inc | |
| Entasis Therapeutics Holdings Inc | |
| Baxalta Inc | |
| Endocyte Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
uniQure NV QURE
Ordinary Shares
|
2025-06-20 | Sell | 2,112 | $14.45 | 30,518 |
|
Cullinan Therapeutics Inc CGEM
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,513 | $0.00 | |
|
uniQure NV QURE
Ordinary Shares
|
2025-06-11 | Grant | 7,970 | $0.00 | |
|
uniQure NV QURE
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 15,630 | $0.00 | |
|
uniQure NV QURE
Ordinary Shares
|
2024-06-19 | Grant | 8,080 | $0.00 | |
|
uniQure NV QURE
Stock Option (Right to Buy) · derivative
|
2024-06-19 | Grant | 15,840 | $0.00 | |
|
uniQure NV QURE
Ordinary Shares
|
2024-06-13 | Sell | 2,229 | $5.12 | 11,412 |
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2024-06-04 | Disposed to issuer | 34,000 | ||
|
Cullinan Therapeutics Inc CGEM
Stock Option (Right to Buy) · derivative
|
2024-05-15 | Grant | 15,618 | $0.00 | |
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2023-10-16 | Grant | 34,000 | $0.00 | |
|
uniQure NV QURE
Ordinary Shares
|
2023-06-16 | Sell | 2,290 | $18.85 | 43,166 |
|
uniQure NV QURE
Stock Option (Right to Buy) · derivative
|
2023-06-13 | Grant | 17,060 | $0.00 | |
|
uniQure NV QURE
Ordinary Shares
|
2023-06-13 | Grant | 8,700 | $0.00 | |
|
uniQure NV QURE
Ordinary Shares
|
2023-02-27 | Sell | 389 | $19.71 | 7,667 |
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2023-01-20 | Grant | 89,379 | $0.00 | |
|
Mirati Therapeutics Inc MRTX
Employee Stock Option (Right to Buy) · derivative
|
2023-01-20 | Grant | 151,233 | $0.00 | |
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2023-01-17 | Sell | 3,179 | $42.38 | 134,726 |
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2022-12-21 | Sell | 4,616 | $40.41 | 186,533 |
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2022-12-19 | Grant | 35,425 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2022-07-11 | Disposed to issuer | 27,500 | $2.20 | 60,500 |
| showing 20 of 70 most recent transactions | |||||